Offer - Urjas Oil for just ₹ 1
Exelon Transdermal Patch 15 (30) is a commercial drug that is prescribed in the form of Patch. Primarily, it is used for the treatment of Alzheimer's Disease, Parkinson's Disease. Secondary and off-label uses of Exelon Transdermal Patch 15 (30) have also been mentioned below.
The optimal dosage of Exelon Transdermal Patch 15 (30) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Exelon Transdermal Patch 15 (30) include Fainting, Indigestion. Some other side effects of Exelon Transdermal Patch 15 (30) have been listed ahead. Normally, these side effects of Exelon Transdermal Patch 15 (30) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Exelon Transdermal Patch 15 (30) is Safe for pregnant women and Mild for women who are breastfeeding. Warnings related to Exelon Transdermal Patch 15 (30)'s effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Kidney Disease, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Exelon Transdermal Patch 15 (30) since this can cause severe adverse effects. Other conditions have been mentioned below in the Exelon Transdermal Patch 15 (30) contraindications section.
Additionally, Exelon Transdermal Patch 15 (30) may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Exelon Transdermal Patch 15 (30), it is important to know that it is not safe while driving, and is not habit-forming.
Exelon Transdermal Patch 15 (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Exelon Transdermal Patch 15 (30) safe for pregnant women?
Exelon is safe to take during pregnancy.
Is the use of Exelon Transdermal Patch 15 (30) safe during breastfeeding?
Exelon may have very limited harmful effects for breastfeeding women.
What is the effect of Exelon Transdermal Patch 15 (30) on the Kidneys?
Exelon rarely affects the kidneys.
What is the effect of Exelon Transdermal Patch 15 (30) on the Liver?
Exelon may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Exelon Transdermal Patch 15 (30) on the Heart?
You can take Exelon without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Exelon Transdermal Patch 15 (30) unless your doctor advises you to do so -
Is this Exelon Transdermal Patch 15 (30) habit forming or addictive?
No, you will not get addicted to Exelon Transdermal Patch 15 (30).
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Exelon Transdermal Patch 15 (30). So it is best to avoid driving.
Is it safe?
Yes, but take Exelon Transdermal Patch 15 (30) only as per medical advice.
Is it able to treat mental disorders?
Exelon Transdermal Patch 15 (30) has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Exelon Transdermal Patch 15 (30)
Taking Exelon Transdermal Patch 15 (30) with food does not cause any problems.
Interaction between Alcohol and Exelon Transdermal Patch 15 (30)
Consumption of alcohol and Exelon Transdermal Patch 15 (30) together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Exelon® (rivastigmine tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 108
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1110-1112
